case 3: parp inhibition in recurrent ovarian cancer
Published 5 years ago • 45 plays • Length 5:26Download video MP4
Download video MP3
Similar videos
-
6:52
case 3: benefit of parp inhibitor maintenance in ovarian cancer
-
2:18
parp inhibition in recurrent ovarian cancer
-
3:48
case 3: maintenance therapy for recurrent ovarian cancer
-
4:58
case 3: second-line therapy for recurrent ovarian cancer
-
3:59
case 3: recurrent ovarian cancer, platinum-sensitive, brca wt
-
1:25
dr. konecny on the indications for parp inhibitors in recurrent ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
27:10
promising advances in low grade serous ovarian cancer
-
11:05
parp inhibitors in recurrent ovarian cancer
-
5:57
case 3: molecular testing in recurrent ovarian cancer
-
1:12
data demonstrate efficacy of 3 parp inhibitors in ovarian cancer
-
3:25
ovarian cancer: recurrence after parp inhibition
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
4:39
recurrent ovarian cancer: third-line therapy and beyond
-
2:53
recurrent ovarian cancer: third-line therapy and beyond
-
6:54
current landscape of parp inhibition in ovarian cancer
-
9:05
case 4: recurrent ovarian cancer, platinum-resistant, brca wt
-
5:11
defining rucaparib’s value in recurrent ovarian cancer